Back to top

Top Ranked Growth Stocks to Buy for March 26th

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 26th:

MCBC Holdings, Inc. (MCFT - Free Report) : This recreational vehicles manufacturer, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.7% over the last 60 days.

MCBC Holdings has a PEG ratio 0.96, compared with 1.24 for the industry. The company possesses a Growth Score of A.

DXC Technology Company (DXC - Free Report) : This information technology services provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.5% over the last 60 days.

DXC Technology has a PEG ratio 1.23, compared with 7.99 for the industry. The company possesses a Growth Score of A.  

Kulicke and Soffa Industries, Inc. (KLIC - Free Report) : This semiconductor equipment manufacturer, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 32% over the last 60 days.

Kulicke and Soffa Industries has a PEG ratio 0.94, compared with 2.19 for the industry. The company possesses a Growth Score of A.

Huntsman Corporation (HUN - Free Report) : This chemical company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 12.8% over the last 60 days.

Huntsman has a PEG ratio 1.28, compared with 1.47 for the industry. The company possesses a Growth Score of A.   

See the full list of top ranked stocks here                         

Learn more about the Growth score and how it is calculated here.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



More from Zacks Zacks #1 Rank Additions

You May Like